Answers are grounded in this paper and cite their sources.
Highly permeable targeted chemotherapy is highly desired for treating non-small cell lung cancer (NSCLC).
No takes yet. Share an insight, caveat, or question.
Wang et al. (2022) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: